Apollo Endosurgery PE Ratio 2006-2019 | APEN

Current and historical p/e ratio for Apollo Endosurgery (APEN) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Apollo Endosurgery PE ratio as of July 19, 2019 is 0.00.
Apollo Endosurgery PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-07-19 3.00 0.00
2019-03-31 3.74 $-1.95 0.00
2018-12-31 3.45 $-2.29 0.00
2018-09-30 7.17 $-1.87 0.00
2018-06-30 6.98 $-1.74 0.00
2018-03-31 6.27 $-1.85 0.00
2017-12-31 5.60 $-2.15 0.00
2017-09-30 4.68 $-36.74 0.00
2017-06-30 7.89 $-36.42 0.00
2017-03-31 12.52 $-41.89 0.00
2016-12-31 12.16 $-45.74 0.00
2016-09-30 18.04 $-15.35 0.00
2016-06-30 11.99 $-21.51 0.00
2016-03-31 14.32 $-15.41 0.00
2015-12-31 17.49 $-21.57 0.00
2015-09-30 14.70 $-43.14 0.00
2015-06-30 21.25 $-52.39 0.00
2015-03-31 190.19 $-70.11 0.00
2014-12-31 217.14 $-77.04 0.00
2014-09-30 271.04 $-50.85 0.00
2014-06-30 305.69 $-35.44 0.00
2014-03-31 365.75 $-17.72 0.00
2013-12-31 328.02 0 0.00
2013-09-30 429.66 0 0.00
2013-06-30 338.80 0 0.00
2013-03-31 386.54 0 0.00
2012-12-31 388.85 $5.39 72.13
2012-09-30 398.86 $5.39 73.98
2012-06-30 404.25 $5.39 74.98
2012-03-31 415.03 $5.39 76.98
2011-12-31 641.41 0 0.00
2011-09-30 458.15 0 0.00
2011-06-30 528.22 0 0.00
2011-03-31 636.02 $-10.78 0.00
2010-12-31 479.71 $-5.39 0.00
2010-09-30 485.10 $-5.39 0.00
2010-06-30 339.57 $64.69 5.25
2010-03-31 425.81 $37.74 11.28
2009-12-31 431.20 $37.74 11.43
2009-09-30 452.76 $21.56 21.00
2009-06-30 765.38 $-70.08 0.00
2009-03-31 506.66 $-59.30 0.00
2008-12-31 565.95 $-123.99 0.00
2008-09-30 517.44 $-107.82 0.00
2008-06-30 662.97 $-86.26 0.00
2008-03-31 970.20 $-59.30 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.067B $0.061B
Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $117.486B 25.70
Intuitive Surgical (ISRG) United States $61.953B 54.10
Edwards Lifesciences (EW) United States $40.257B 40.22
IDEXX Laboratories (IDXX) United States $24.940B 65.43
Fresenius Medical Care AG KGaA (FMS) Germany $23.554B 15.48
Teleflex (TFX) United States $15.715B 34.05
Olympus (OCPNY) Japan $14.818B 110.87
SONOVA HOLDING (SONVY) Switzerland $14.646B 0.00
Sysmex ADR (SSMXY) Japan $14.258B 38.44
DexCom (DXCM) United States $13.966B 273.91
Hologic (HOLX) United States $13.000B 20.91
STERIS (STE) Ireland $12.503B 30.24
Varian Medical Systems (VAR) United States $12.310B 31.41
ABIOMED (ABMD) United States $11.899B 72.39
Masimo (MASI) United States $8.224B 50.39
Penumbra (PEN) United States $6.144B 260.09
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.087B 38.33
Integra LifeSciences Holdings (IART) United States $4.688B 22.03
Globus Medical (GMED) United States $4.267B 26.61
Tandem Diabetes Care (TNDM) United States $3.714B 0.00
LivaNova (LIVN) United Kingdom $3.587B 23.38
Wright Medical Group (WMGI) Netherlands $3.391B 672.25
Cantel Medical (CMD) United States $3.328B 33.77
Glaukos (GKOS) United States $2.775B 0.00
Integer Holdings (ITGR) United States $2.670B 19.67
Nihon Kohden (NHNKY) Japan $2.395B 24.10
Nevro (NVRO) United States $1.931B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.928B 30.51
Inogen (INGN) United States $1.312B 29.03
OPKO Health (OPK) United States $1.280B 0.00
Silk Road Medical (SILK) United States $1.268B 0.00
Veracyte (VCYT) United States $1.229B 0.00
CryoLife (CRY) United States $1.135B 112.63
Accelerate Diagnostics (AXDX) United States $1.023B 0.00
Tactile Systems Technology (TCMD) United States $1.022B 150.86
ORTHOFIX MEDICAL INC (OFIX) United States $0.977B 28.31
Luminex (LMNX) United States $0.906B 118.53
Pacific Biosciences Of California (PACB) United States $0.898B 0.00
ViewRay (VRAY) United States $0.894B 0.00
Natus Medical (BABY) United States $0.889B 20.59
Mesa Laboratories (MLAB) United States $0.877B 41.26
AngioDynamics (ANGO) United States $0.801B 26.26
Fluidigm (FLDM) United States $0.793B 0.00
AxoGen (AXGN) United States $0.784B 0.00
Quotient (QTNT) Switzerland $0.703B 0.00
Intersect ENT (XENT) United States $0.652B 0.00
Corindus Vascular Robotics (CVRS) United States $0.579B 0.00
OrthoPediatrics (KIDS) United States $0.525B 0.00
Si-Bone (SIBN) United States $0.496B 0.00
GenMark Diagnostics (GNMK) United States $0.353B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.349B 18.71
Accuray (ARAY) United States $0.334B 0.00
Semler Scientific (SMLR) United States $0.306B 60.64
RTI Surgical (RTIX) United States $0.302B 37.18
TransEnterix (TRXC) United States $0.296B 0.00
SeaSpine Holdings (SPNE) United States $0.242B 0.00
Neuronetics (STIM) United States $0.232B 0.00
Alphatec Holdings (ATEC) United States $0.217B 0.00
ConforMIS (CFMS) United States $0.217B 0.00
IRadimed (IRMD) United States $0.205B 39.13
CRH Medical (CRHM) Canada $0.199B 69.00
Sientra (SIEN) United States $0.180B 0.00
Stereotaxis (STXS) United States $0.170B 0.00
Second Sight Medical Products (EYES) United States $0.113B 0.00
Sensus Healthcare (SRTS) United States $0.088B 0.00
Ekso Bionics Holdings (EKSO) United States $0.087B 0.00
Vermillion (VRML) United States $0.079B 0.00
EDAP TMS S.A (EDAP) France $0.079B 0.00
T2 Biosystems (TTOO) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.072B 0.00
Spectral Diagnostics (EDTXF) Canada $0.064B 0.00
Helius Medical Technologies (HSDT) United States $0.054B 0.00